Alzamend Neuro (ALZN) Stock Chart & Stock Price History → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free ALZN Stock Alerts $0.67 +0.04 (+6.39%) (As of 10:19 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alzamend Neuro Stock Price Performance5 Day Performance+3.85%1 Month Performance-0.22%3 Month Performance-22.08%6 Month Performance-38.17%Year-To-Date Performance-24.27%1 Year Performance-91.01% Receive ALZN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. ALZN Stock Chart for Tuesday, May, 21, 2024 ALZN Chart by TradingView Alzamend Neuro Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2024$0.63$0.64+0.74%$0.66$0.6227,849 shs$4.39 million05/17/2024$0.65$0.63-2.37%$0.68$0.6031,506 shs$4.36 million05/16/2024$0.62$0.65+4.68%$0.66$0.6195,343 shs$4.47 million05/15/2024$0.61$0.62+2.16%$0.64$0.5768,459 shs$4.27 million05/14/2024$0.51$0.61+20.18%$0.72$0.51479,492 shs$4.17 million05/13/2024$0.54$0.51-7.03%$0.55$0.49105,394 shs$3.47 million Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 05/10/2024$0.59$0.54-7.93%$0.57$0.5053,113 shs$3.73 million05/09/2024$0.53$0.59+11.32%$0.59$0.48390,892 shs$4.05 million05/08/2024$0.56$0.53-5.84%$0.60$0.5283,072 shs$3.64 million05/07/2024$0.70$0.56-20.02%$0.71$0.44478,123 shs$3.87 million05/06/2024$0.73$0.70-3.06%$0.74$0.7029,656 shs$4.83 million05/03/2024$0.74$0.73-1.22%$0.74$0.7218,974 shs$4.99 million05/02/2024$0.72$0.74+2.37%$0.74$0.7025,266 shs$5.05 million05/01/2024$0.71$0.72+0.98%$0.77$0.7038,343 shs$4.88 million04/30/2024$0.71$0.71+0.14%$0.78$0.7117,518 shs$4.89 million04/29/2024$0.72$0.71-1.32%$0.75$0.7021,110 shs$4.88 million04/26/2024$0.70$0.73+4.71%$0.74$0.7013,934 shs$5.04 million04/25/2024$0.71$0.70-1.30%$0.73$0.7025,277 shs$4.81 million04/24/2024$0.73$0.71-2.26%$0.73$0.7119,670 shs$4.87 million04/23/2024$0.69$0.73+5.47%$0.73$0.6919,567 shs$4.99 million04/22/2024$0.68$0.69+1.85%$0.70$0.6748,450 shs$4.72 million04/19/2024$0.69$0.68-2.24%$0.71$0.6527,986 shs$4.64 million04/18/2024$0.72$0.69-4.57%$0.72$0.6820,159 shs$4.75 million04/17/2024$0.78$0.72-7.17%$0.77$0.7058,033 shs$4.98 million04/16/2024$0.74$0.78+5.26%$0.84$0.7454,619 shs$5.36 million04/15/2024$0.85$0.74-12.82%$0.88$0.74114,685 shs$5.09 million04/12/2024$0.90$0.85-5.11%$0.90$0.8532,928 shs$5.84 million04/11/2024$0.90$0.90+0.09%$0.93$0.898,396 shs$6.15 million04/10/2024$0.91$0.90-2.00%$0.93$0.885,357 shs$6.15 million04/09/2024$0.88$0.91+3.43%$0.93$0.8826,685 shs$6.27 million04/08/2024$0.89$0.88-0.24%$0.93$0.8751,887 shs$6.06 million04/05/2024$0.92$0.89-4.21%$0.93$0.8959,604 shs$6.08 million04/04/2024$0.89$0.92+4.41%$0.93$0.8946,719 shs$6.35 million04/03/2024$0.91$0.89-2.64%$0.94$0.8920,562 shs$6.08 million04/02/2024$0.89$0.91+2.20%$0.93$0.8871,204 shs$6.25 million04/01/2024$1.00$0.89-11.06%$0.99$0.86198,533 shs$6.11 million03/29/2024$1.00$1.00$1.04$0.9816,662 shs$6.87 million03/28/2024$1.02$1.00-1.96%$1.04$0.9816,655 shs$6.87 million03/27/2024$0.99$1.02+2.66%$1.05$0.9619,089 shs$7.26 million03/26/2024$1.02$0.99-2.59%$1.04$0.9567,078 shs$7.07 millionEverybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.03/25/2024$1.07$1.02-4.67%$1.07$1.0062,378 shs$7.26 million03/22/2024$1.05$1.07+1.90%$1.07$1.0131,036 shs$7.62 million03/21/2024$1.04$1.05+0.96%$1.10$1.0221,598 shs$7.48 million03/20/2024$1.06$1.04-1.89%$1.10$1.0056,742 shs$7.41 million03/19/2024$0.97$1.06+9.28%$1.08$0.9648,877 shs$7.55 million03/18/2024$0.93$0.97+4.30%$1.02$0.9332,369 shs$6.91 million03/15/2024$0.97$0.93-4.12%$0.97$0.9354,373 shs$6.62 million03/14/2024$1.05$0.97-7.62%$1.05$0.93115,302 shs$6.91 million03/13/2024$1.12$1.05-6.25%$1.10$0.95121,125 shs$7.48 million03/12/2024$1.20$1.12-6.67%$1.22$1.0660,282 shs$7.97 million03/11/2024$1.18$1.20+1.69%$1.24$1.1553,344 shs$8.54 million03/08/2024$1.06$1.18+11.32%$1.20$1.06108,093 shs$8.40 million03/07/2024$1.12$1.06-5.36%$1.10$1.00126,694 shs$7.55 million03/06/2024$1.17$1.12-4.27%$1.27$1.05265,087 shs$7.97 million03/05/2024$0.97$1.17+20.80%$1.29$0.95694,545 shs$8.33 million03/04/2024$0.92$0.97+5.50%$0.97$0.9182,340 shs$6.90 million03/01/2024$0.90$0.94+4.44%$0.94$0.9014,297 shs$6.69 million02/29/2024$0.91$0.90-1.10%$0.94$0.9026,783 shs$6.41 million02/28/2024$0.91$0.91$0.92$0.8818,467 shs$6.48 million02/27/2024$0.91$0.91+0.50%$0.92$0.9011,116 shs$6.48 million02/26/2024$0.90$0.91+1.07%$0.92$0.8821,028 shs$6.45 million02/23/2024$0.89$0.90+0.17%$0.90$0.8823,443 shs$6.38 million02/22/2024$0.87$0.89+3.40%$0.90$0.8612,405 shs$6.37 million02/21/2024$0.90$0.87-3.89%$0.90$0.8612,745 shs$6.16 million02/20/2024$0.85$0.90+5.88%$0.90$0.8550,911 shs$6.41 million Related Companies: Cyclacel Pharmaceuticals Stock Chart Petros Pharmaceuticals Stock Chart Exicure Stock Chart Ensysce Biosciences Stock Chart Soligenix Stock Chart Tharimmune Stock Chart Clever Leaves Stock Chart GT Biopharma Stock Chart Seelos Therapeutics Stock Chart ZyVersa Therapeutics Stock Chart Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALZN) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.